Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes.

Authors: Baker N,Glover L,Munday JC,Aguinaga Andrés D,Barrett MP,de Koning HP,Horn D,
Address: Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom.
Journal: Proc Natl Acad Sci U S A.


Publication: 2012 Jul 3;109(27):10996-1001. doi: 10.1073/pnas.1202885109. Epub 2012 Jun 18.
Free Text: Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes.

abstract

African trypanosomes cause sleeping sickness in humans, a disease that is typically fatal without chemotherapy. Unfortunately, drug resistance is common and melarsoprol-resistant trypanosomes often display cross-resistance to pentamidine. Although melarsoprol/pentamidine cross-resistance (MPXR) has been an area of intense interest for several decades, our understanding of the underlying mechanisms remains incomplete. Recently, a locus encoding two closely related Aquaglyceroporins, AQP2 and AQP3, was linked to MPXR in a high-throughput loss-of-function screen. Here, we show that AQP2 has an unconventional "selectivity filter." AQP2-specific gene knockout generated MPXR trypanosomes but did not affect resistance to a lipophilic arsenical, whereas recombinant AQP2 reversed MPXR in cells lacking native AQP2 and AQP3. AQP2 was also shown to be disrupted in a laboratory-selected MPXR strain. Both AQP2 and AQP3 gained access to the surface plasma membrane in insect life-cycle-stage trypanosomes but, remarkably, AQP2 was specifically restricted to the flagellar pocket in the bloodstream stage. We conclude that the unconventional aquaglyceroporin, AQP2, renders cells sensitive to both melarsoprol and pentamidine and that loss of AQP2 function could explain cases of innate and acquired MPXR.



Related Articles
High-throughput decoding of antitrypanosomal drug efficacy and resistance.
Nature. 2012
High-throughput decoding of antitrypanosomal drug efficacy and resistance.
Alsford S, Eckert S, Baker N, Glover L, Sanchez-Flores A, Leung KF, Turner DJ, Field MC, Berriman M, Horn D. Nature. 2012 Jan 25; 482(7384):232-6. Epub 2012 Jan 25.
Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
Exp Parasitol. 1997
Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
Scott AG, Tait A, Turner CM. Exp Parasitol. 1997 Jul; 86(3):181-90.
Review Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
Parasitol Res. 2003
Review Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
Nok AJ. Parasitol Res. 2003 May; 90(1):71-9. Epub 2003 Jan 31.
Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance.
Int J Parasitol. 2007
Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance.
Bernhard SC, Nerima B, Mäser P, Brun R. Int J Parasitol. 2007 Nov; 37(13):1443-8. Epub 2007 May 29.
Review Drug resistance in human African trypanosomiasis.
Future Microbiol. 2011
Review Drug resistance in human African trypanosomiasis.
Barrett MP, Vincent IM, Burchmore RJ, Kazibwe AJ, Matovu E. Future Microbiol. 2011 Sep; 6(9):1037-47.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.